$ONVO
ORGANOVO HOLDINGS, INC.

2014 Q2 Form 10-K Financial Statement

#000119312514232145 Filed on June 10, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2014
Revenue $99.00K $120.0K $379.0K
YoY Change -6.6% -44.19% 72.27%
Cost Of Revenue $0.00
YoY Change
Gross Profit $120.0K $379.0K
YoY Change -44.19% 72.27%
Gross Profit Margin 100.0% 100.0%
Selling, General & Admin $3.695M $4.250M $13.05M
YoY Change 56.7% 52.22% 367.89%
% of Gross Profit 3541.67% 3444.33%
Research & Development $2.814M $2.550M $7.974M
YoY Change 89.88% 76.1% 449.93%
% of Gross Profit 2125.0% 2103.96%
Depreciation & Amortization $96.00K $100.0K $387.0K
YoY Change 3.23% 25.0% 383.75%
% of Gross Profit 83.33% 102.11%
Operating Expenses $6.509M $6.800M $21.03M
YoY Change 69.51% 60.38% 395.94%
Operating Profit -$6.410M -$6.680M -$20.65M
YoY Change 71.67% 65.96% 413.66%
Interest Expense $0.00 $13.00K $13.00K
YoY Change -100.0% -80.0% -100.11%
% of Operating Profit
Other Income/Expense, Net -$23.00K $0.00 -$5.199M
YoY Change -37.84% -100.0%
Pretax Income -$6.430M -$6.480M -$25.85M
YoY Change 70.56% -59.8% 60.36%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.433M -$6.480M -$25.85M
YoY Change 70.59% -59.8% 60.35%
Net Earnings / Revenue -6497.98% -5400.0% -6820.05%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.645M -$1.666M -$7.063M
COMMON SHARES
Basic Shares Outstanding 78.28M shares 77.82M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2014 Q1 2014
SHORT-TERM ASSETS
Cash & Short-Term Investments $44.90M $48.17M $48.17M
YoY Change 249.42% 208.19% 208.19%
Cash & Equivalents $44.90M $48.17M $48.17M
Short-Term Investments
Other Short-Term Assets $710.0K $930.0K $930.0K
YoY Change 115.15% 181.82% 181.82%
Inventory $71.00K $63.00K $60.00K
Prepaid Expenses
Receivables $60.00K
Other Receivables $0.00
Total Short-Term Assets $45.74M $49.16M $49.16M
YoY Change 244.95% 204.52% 204.58%
LONG-TERM ASSETS
Property, Plant & Equipment $1.001M $857.0K $860.0K
YoY Change -9.82% -17.99% -18.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $88.00K $89.00K $170.0K
YoY Change -32.31% -9.18% -10.53%
Total Long-Term Assets $1.168M $1.025M $1.030M
YoY Change -6.56% -16.73% -16.94%
TOTAL ASSETS
Total Short-Term Assets $45.74M $49.16M $49.16M
Total Long-Term Assets $1.168M $1.025M $1.030M
Total Assets $46.91M $50.19M $50.19M
YoY Change 223.28% 188.84% 188.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $839.0K $326.0K $330.0K
YoY Change 126.76% -49.14% -48.44%
Accrued Expenses $1.739M $822.0K $1.170M
YoY Change 52.54% 5.38% 50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $380.0K $380.0K
YoY Change
Long-Term Debt Due $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $3.085M $1.893M $1.890M
YoY Change -59.3% -77.42% -77.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $10.00K $10.00K
YoY Change -100.0% -50.0% -50.0%
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Total Long-Term Liabilities $0.00 $10.00K $10.00K
YoY Change -100.0% -66.67% -66.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.085M $1.893M $1.890M
Total Long-Term Liabilities $0.00 $10.00K $10.00K
Total Liabilities $3.090M $1.902M $1.900M
YoY Change -59.34% -77.37% -77.41%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $78.00K $140.5M
YoY Change 216049.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.82M $48.28M $48.28M
YoY Change
Total Liabilities & Shareholders Equity $46.91M $50.19M $50.19M
YoY Change 223.28% 188.84% 188.78%

Cashflow Statement

Concept 2014 Q2 2014 Q1 2014
OPERATING ACTIVITIES
Net Income -$6.433M -$6.480M -$25.85M
YoY Change 70.59% -59.8% 60.35%
Depreciation, Depletion And Amortization $96.00K $100.0K $387.0K
YoY Change 3.23% 25.0% 383.75%
Cash From Operating Activities $3.400M -$5.400M -$15.56M
YoY Change -227.82% 95.65% 463.8%
INVESTING ACTIVITIES
Capital Expenditures $238.0K -$120.0K $277.0K
YoY Change 46.01% -187.59% -273.13%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $10.00K
YoY Change -100.0%
Cash From Investing Activities -$240.0K -$120.0K -$270.0K
YoY Change 118.18% -25.0% 68.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 330.0K 3.870M 48.37M
YoY Change 4.03% 1200.27%
NET CHANGE
Cash From Operating Activities 3.400M -5.400M -15.56M
Cash From Investing Activities -240.0K -120.0K -270.0K
Cash From Financing Activities 330.0K 3.870M 48.37M
Net Change In Cash 3.400M -1.650M -15.56M
YoY Change -222.74% -306.25% -2045.13%
FREE CASH FLOW
Cash From Operating Activities $3.400M -$5.400M -$15.56M
Capital Expenditures $238.0K -$120.0K $277.0K
Free Cash Flow $3.162M -$5.280M -$15.84M
YoY Change -212.01% 82.26% 509.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
4.50
CY2011Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.00
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
75000 shares
CY2013Q4 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03 pure
CY2013Q4 onvo Lease Amendment Effective Date
LeaseAmendmentEffectiveDate
2014-09-01
CY2013Q4 onvo Increased Office Space Headquarters
IncreasedOfficeSpaceHeadquarters
15268 sqft
CY2013Q4 onvo Additional Leased Office Space
AdditionalLeasedOfficeSpace
15539 sqft
CY2007Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78113639 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1546377 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78113639 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
573495 shares
CY2014Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11401937 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03 pure
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
78000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50186000
CY2014Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
31000
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
4000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.87
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5935888 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.73
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1167000
CY2014Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
10000
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
574000
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
11000
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Next Rolling Twelve Months
OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths
766000
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
140419000
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
7210000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
326000
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2014Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
283000
CY2014Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2244000
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1893000
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2439000
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
986000
CY2014Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
377000
CY2014Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
505000
CY2014Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48284000
CY2014Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
5000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
48284000
CY2014Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
15000
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive
1034000
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Four
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour
1004000
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Two
OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo
981000
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13000
CY2014Q1 us-gaap Liabilities
Liabilities
1902000
CY2014Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
34000
CY2014Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4000
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
15000
CY2014Q1 us-gaap Accrued Rent Current
AccruedRentCurrent
345000
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
CY2014Q1 us-gaap Assets Current
AssetsCurrent
49161000
CY2014Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1941000
CY2014Q1 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
89000
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
CY2014Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
34833000
CY2014Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2244000
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
780000
CY2013Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
10000
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
270000
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
75269000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
641000
CY2013Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
53000
CY2014Q1 us-gaap Assets
Assets
50186000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48167000
CY2014Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
33000
CY2014Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2014Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
1000
CY2014Q1 us-gaap Inventory Net
InventoryNet
63000
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1431000
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7733041
CY2014Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
92213000
CY2014Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
280000
CY2014Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
40000
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
891000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20482823
CY2014Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
79000
CY2014Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
191000
CY2014Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
78800
CY2014Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
34838000
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
16045500
CY2014Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1207000
CY2014Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
63000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
857000
CY2014Q1 onvo Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
22000
CY2014Q1 onvo Royalty Payments Under License Agreement Due Next Year
RoyaltyPaymentsUnderLicenseAgreementDueNextYear
4000
CY2014Q1 onvo Net Operating Loss Carryforwards Related To Windfall Tax Benefits
NetOperatingLossCarryforwardsRelatedToWindfallTaxBenefits
3389000
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78276250 shares
CY2011Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.20 pure
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10353000
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64686919 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64686919 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
985742 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.11
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3618567 shares
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
967000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8382000
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1045000
CY2013Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
6898000
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
386000
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8969000
CY2013Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
15000
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
8969000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
53000
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
65000
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17375000
CY2013Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2013Q1 us-gaap Liabilities
Liabilities
8406000
CY2013Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
71000
CY2013Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
9000
CY2013Q1 us-gaap Accrued Rent Current
AccruedRentCurrent
270000
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q1 us-gaap Assets Current
AssetsCurrent
16144000
CY2013Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
743000
CY2013Q1 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
98000
CY2013Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
CY2013Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
967000
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
50000
CY2013Q1 us-gaap Assets
Assets
17375000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15628000
CY2013Q1 us-gaap Grants Receivable
GrantsReceivable
101000
CY2013Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
33000
CY2013Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2013Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
1000
CY2013Q1 us-gaap Inventory Net
InventoryNet
88000
CY2013Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1315000
CY2013Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
66365000
CY2013Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
224000
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
327000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5909154
CY2013Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
88000
CY2013Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
114000
CY2013Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
38300
CY2013Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1168000
CY2013Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
88000
CY2013Q1 onvo Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
-1000
CY2013Q3 dei Entity Public Float
EntityPublicFloat
394475790
CY2007Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2007Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
CY2008Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
12562486 shares
CY2008Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-96000
CY2009Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7319904 shares
CY2009Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-966000
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
4283082 shares
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2010Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2301000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
285000
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2011Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2909750 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1111295 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.08
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
896256 shares
CY2011Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.00
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1835000
CY2011Q4 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
527600
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
340000
CY2011Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1260300
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58535411 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
21347182 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58535411 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1162044 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.48
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2690586 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
650000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.00
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
981000
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
10000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
192000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
44883000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
425000
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
850000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22035000
CY2012Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
20619000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
720000
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5303000
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
17000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-5303000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
114000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
250000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-242000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
59000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16749000
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2012Q4 us-gaap Liabilities
Liabilities
22052000
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
73000
CY2012Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
188000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
32742000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
15866000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
562000
CY2012Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
81000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
850000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
50000
CY2012Q4 us-gaap Assets
Assets
16749000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14817000
CY2012Q4 us-gaap Grants Receivable
GrantsReceivable
162000
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
33000
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2012Q4 us-gaap Inventory Net
InventoryNet
360000
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
196000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
906000
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
50245000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
290000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
527000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3041476
CY2012Q4 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
88000
CY2012Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
114000
CY2012Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
38300
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
60000
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
759000
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
104000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
714000
CY2012Q4 onvo Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
-2000
CY2013Q4 onvo Net Rentable Area Expanded
NetRentableAreaExpanded
15268 sqft
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2390000
CY2013Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
43400000
CY2013Q3 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
3200000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-31339000
us-gaap Revenues
Revenues
3442000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
647000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
478000
us-gaap Interest Paid
InterestPaid
10000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
19000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
726000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1198000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
27092000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
224000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30000
us-gaap Income Taxes Paid
IncomeTaxesPaid
3000
us-gaap Investment Income Interest
InvestmentIncomeInterest
29000
CY2013Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43400000
CY2014 dei Entity Registrant Name
EntityRegistrantName
ORGANOVO HOLDINGS, INC.
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2011Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
7676828 shares
CY2011Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
3030000
us-gaap Profit Loss
ProfitLoss
-92213000
us-gaap Revenue From Grants
RevenueFromGrants
1074000
us-gaap Operating Income Loss
OperatingIncomeLoss
-38341000
CY2011Q4 onvo Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2011Q4 onvo Debt Conversion Accrued Interest Amount
DebtConversionAccruedInterestAmount
459800
CY2014 dei Trading Symbol
TradingSymbol
ONVO
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-53872000
onvo Warrant Or Right Expense Or Revenue Recognized
WarrantOrRightExpenseOrRevenueRecognized
163000
onvo Increase Decrease In Cash Deposits Released From Restriction
IncreaseDecreaseInCashDepositsReleasedFromRestriction
-79000
us-gaap Profit Loss
ProfitLoss
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0060 pure
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9690 pure
CY2013Q4 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
528000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
134000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
80897000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
17000
CY2013Q4 onvo Warrant Earning Period Through Issuance Of Common Stock
WarrantEarningPeriodThroughIssuanceOfCommonStock
P12M
CY2012Q1 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
1525387 Investment
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10350000 shares
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
2130000
us-gaap Share Based Compensation
ShareBasedCompensation
6900000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
48167000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1391000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1167000
us-gaap Interest Expense
InterestExpense
3484000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
326000
us-gaap Cost Of Services Amortization
CostOfServicesAmortization
1140000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16056000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
420000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
818000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
250000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
438000
us-gaap Depreciation
Depreciation
794000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1317200
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2084000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25593000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4630000
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
76454000
onvo Fair Value Of Warrant Liabilities In Excess Of Proceeds Received
FairValueOfWarrantLiabilitiesInExcessOfProceedsReceived
19019000
onvo Interest Accrued On Convertible Notes Payable
InterestAccruedOnConvertibleNotesPayable
495000
onvo Loss On Inducement To Exercise
LossOnInducementToExercise
1904000
onvo Payment For Expense On Warrant Modification
PaymentForExpenseOnWarrantModification
77000
onvo Repayment Of Convertible Notes And Interest Payable
RepaymentOfConvertibleNotesAndInterestPayable
110000
onvo Revenue From Collaborations
RevenueFromCollaborations
2144000
CY2014 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001497253
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
60000 shares
CY2014 us-gaap Revenue Recognition Multiple Element Arrangements
RevenueRecognitionMultipleElementArrangements
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> Revenue Arrangements with Multiple Deliverables</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The Company occasionally enters into revenue arrangements that contain multiple deliverables. Judgment is required to properly identify the accounting units of the multiple deliverable transactions and to determine the manner in which revenue should be allocated among the accounting units. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria of revenue recognition have been met for each deliverable in order for revenue recognition to occur in the appropriate accounting period. For multiple deliverable agreements, consideration is allocated at the inception of the agreement to all deliverables based on their relative selling price. The relative selling price for each deliverable is determined using VSOE of selling price or third-party evidence of selling price if VSOE does not exist. If neither VSOE nor third-party evidence of selling price exists, the Company uses its best estimate of the selling price for the deliverable.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The Company recognizes revenue for delivered elements only when it determines there are no uncertainties regarding customer acceptance. While changes in the allocation of the arrangement consideration between the units of accounting will not affect the amount of total revenue recognized for a particular sales arrangement, any material changes in these allocations could impact the timing of revenue recognition, which could affect the Company&#x2019;s results of operations.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The Company expects to periodically receive license fees for non-exclusive research licensing associated with funded research projects. License fees under these arrangements are recognized over the term of the contract or development period as it has been determined that such licenses do not have stand-alone value.</p> </div>
CY2014 us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> Product Revenue</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The Company recognizes product revenue at the time of shipment to the customer, provided all other revenue recognition criteria have been met. The Company recognizes product revenues upon shipment to distributors, provided that (i)&#xA0;the price is substantially fixed or determinable at the time of sale; (ii)&#xA0;the distributor&#x2019;s obligation to pay the Company is not contingent upon resale of the products; (iii)&#xA0;title and risk of loss passes to the distributor at time of shipment; (iv)&#xA0;the distributor has economic substance apart from that provided by the Company; (v)&#xA0;the Company has no significant obligation to the distributor to bring about resale of the products; and (vi)&#xA0;future returns can be reasonably estimated. For any sales that do not meet all of the above criteria, revenue is deferred until all such criteria have been met.</p> </div>
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0132 pure
CY2014 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
1 for 1 basis
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7822 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y11M1D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73139618 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.63
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15561000
CY2014 us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
The estimated useful lives of the fixed assets range between two and five years.
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.92
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15561000
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.19
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2519572 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
18455 shares
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y6M
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
183796 shares
CY2014 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <i>Reclassifications</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Certain reclassifications were made to the 2011 financial statements in order to conform to the presentation of the financial statements for 2012. The reclassifications did not have any effect on previously reported net loss or stockholders&#x2019; equity (deficit).</p> </div>
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.31
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-268000
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
387000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7974000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
402000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
387000
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7700000 shares
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <i>Use of estimates</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates used in preparing the consolidated financial statements include those assumed in computing the valuation of warrants and conversion features, revenue recognized under the proportional performance model, the valuation of stock-based compensation expense, and the valuation allowance on deferred tax assets.</p> </div>
CY2014 us-gaap Interest Expense
InterestExpense
13000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-315000
CY2014 us-gaap Cost Of Services Amortization
CostOfServicesAmortization
323000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
472247 shares
CY2014 us-gaap Revenues
Revenues
379000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
392000
CY2014 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
40000
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
CY2014 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
492000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
402000
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
18000
CY2014 us-gaap Profit Loss
ProfitLoss
-25848000
CY2014 us-gaap Revenue From Grants
RevenueFromGrants
131000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-20649000
CY2014 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
CY2014 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-84000
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1277000
CY2014 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
10000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5199000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-25000
CY2014 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4600000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
277000
CY2014 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5120000
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
48368000
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-45000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1002419
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
4600000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
32539000
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2014 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
6800
CY2014 us-gaap Depreciation
Depreciation
380000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
561500
CY2014 us-gaap Restructuring Costs
RestructuringCosts
2100000
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13054000
CY2014 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
CY2014 onvo Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
3201633 shares
CY2014 onvo Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
38800
CY2014 onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
48016000
CY2014 onvo Stock Issued During Period Value Public Offering
StockIssuedDuringPeriodValuePublicOffering
46915000
CY2014 onvo Adjustments To Additional Paid In Capital Expense On Modification Of Warrant
AdjustmentsToAdditionalPaidInCapitalExpenseOnModificationOfWarrant
12000
CY2014 onvo Adjustments To Additional Paid In Capital Warrant Liability From Exercises Of Warrants
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityFromExercisesOfWarrants
10874000
CY2014 onvo Adjustments To Additional Paid In Capital Warrant Liability Reclassified To Equity
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityReclassifiedToEquity
767000
CY2014 onvo Companys Stockholders Retained Voting Interest
CompanysStockholdersRetainedVotingInterest
0.25 pure
CY2014 onvo Deduction In Warrant Liability
DeductionInWarrantLiability
10874000
CY2014 onvo Federal And State Net Operating Loss Carry Forwards Expiration Year Start
FederalAndStateNetOperatingLossCarryForwardsExpirationYearStart
2028
CY2014 onvo Fee For Additional Research And Development Services
FeeForAdditionalResearchAndDevelopmentServices
135000
CY2014 onvo Former Security Holders Common Stock Voting Interest
FormerSecurityHoldersCommonStockVotingInterest
0.75 pure
CY2014 onvo Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-101000
CY2014 onvo Issued Warrants To Purchase Share Of Common Stock For Consulting Services Shares
IssuedWarrantsToPurchaseShareOfCommonStockForConsultingServicesShares
75000 shares
CY2014 onvo Lease Term With Option To Extend
LeaseTermWithOptionToExtend
P48M
CY2014 onvo Payment For Expense On Warrant Modification
PaymentForExpenseOnWarrantModification
12000
CY2014 onvo Research And Development Services Contract Value
ResearchAndDevelopmentServicesContractValue
1500000
CY2014 onvo Revenue From Collaborations
RevenueFromCollaborations
248000
CY2014 onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
2713207 shares
CY2014 onvo Stockholders Equity During Period Value Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodValueIssuanceOfCommonStockFromWarrantExercises
1101000
CY2014 onvo Warrant Or Right Expense Or Revenue Recognized
WarrantOrRightExpenseOrRevenueRecognized
72000
CY2014 onvo Warrant Reclassified Equity Instruments
WarrantReclassifiedEquityInstruments
767000
CY2014 onvo Increase Decrease In Cash Deposits Released From Restriction
IncreaseDecreaseInCashDepositsReleasedFromRestriction
9000
CY2014 onvo Issued Warrants To Purchase Shares Of Common Stock Or Consulting Services
IssuedWarrantsToPurchaseSharesOfCommonStockOrConsultingServices
404000
CY2014 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
1920874 shares
CY2014 onvo Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Forfeited Cancelled Surrendered In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedCancelledSurrenderedInPeriod
shares
CY2009 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
130422 shares
CY2009 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
5373004 shares
CY2009 us-gaap Profit Loss
ProfitLoss
-872000
CY2009 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2000
CY2009 onvo Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Forfeited Cancelled Surrendered In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedCancelledSurrenderedInPeriod
shares
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
219369 shares
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
3256191 shares
CY2010 us-gaap Profit Loss
ProfitLoss
-1339000
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4000
CY2010 onvo Issuance Of Restricted Common Stock To Employees And Non Employees Shares
IssuanceOfRestrictedCommonStockToEmployeesAndNonEmployeesShares
219369 shares
CY2010 onvo Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Forfeited Cancelled Surrendered In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedCancelledSurrenderedInPeriod
shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
61406 shares
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22925694 shares
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.08
CY2011 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1914000
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
896256 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2011 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6400000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
3233193 shares
CY2011 us-gaap Revenues
Revenues
969000
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
69000
CY2011 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
438000
CY2011 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
224000
CY2011 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000
CY2011 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1111000
CY2011 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
239000
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
CY2011 us-gaap Profit Loss
ProfitLoss
-4383000
CY2011 us-gaap Revenue From Grants
RevenueFromGrants
57000
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-2305000
CY2011 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
65000
CY2011 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
250000
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2078000
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
224000
CY2011 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2011 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3490000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9000
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46000
CY2011 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
7000
CY2011 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
528000
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
121000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2080000
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
46000
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
9000
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
55000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-111000
CY2011 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
132000
CY2011 us-gaap Interest Expense
InterestExpense
2067000
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
373000
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1420000
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
68000
CY2011 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
225000
CY2011 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
119000
CY2011 us-gaap Depreciation
Depreciation
63000
CY2011 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
145200
CY2011 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1188000
CY2011 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1733000
CY2011 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2543000
CY2011 onvo Accrued Interest On Convertible Notes
AccruedInterestOnConvertibleNotes
460000
CY2011 onvo Convertible Notes Principal Amount
ConvertibleNotesPrincipalAmount
3030000
CY2011 onvo Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-60000
CY2011 onvo Interest Accrued On Convertible Notes Payable
InterestAccruedOnConvertibleNotesPayable
232000
CY2011 onvo Issuance Of Common Stock To Note Holders Shares
IssuanceOfCommonStockToNoteHoldersShares
7676828 shares
CY2011 onvo Revenue From Collaborations
RevenueFromCollaborations
688000
CY2011 onvo Warrant Discount
WarrantDiscount
583700
CY2011 onvo Warrants And Related Beneficial Conversion Feature Value
WarrantsAndRelatedBeneficialConversionFeatureValue
823000
CY2011 onvo Warrant Issued In Connection With Convertible Notes Payable
WarrantIssuedInConnectionWithConvertibleNotesPayable
1260000
CY2011 onvo Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Forfeited Cancelled Surrendered In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedCancelledSurrenderedInPeriod
shares
CY2008 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
12627697 shares
CY2008 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
65211 shares
CY2008 us-gaap Profit Loss
ProfitLoss
-98000
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2000
CY2008 onvo Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Forfeited Cancelled Surrendered In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedCancelledSurrenderedInPeriod
shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1380000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0089 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9622 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y18D
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43149657 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.95
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9693000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.50
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.01
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.08
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2023394 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
5000 shares
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
224064 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.25
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15200000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1233409 shares
CY2012 us-gaap Revenues
Revenues
1197000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
101000
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
CY2012 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
890000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18000
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000
CY2012 us-gaap Profit Loss
ProfitLoss
-43553000
CY2012 us-gaap Revenue From Grants
RevenueFromGrants
162000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-9319000
CY2012 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
CY2012 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-158000
CY2012 us-gaap Payments For Commissions
PaymentsForCommissions
1372260
CY2012 us-gaap Interest Paid
InterestPaid
10000
CY2012 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
7000
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-34234000
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
459000
CY2012 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1435000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
357000
CY2012 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
9931000
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
24615000
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-153000
CY2012 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
2130000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
564641
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
1435000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14477000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-445000
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
543000
CY2012 us-gaap Interest Expense
InterestExpense
1088000
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-233000
CY2012 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
32743000
CY2012 us-gaap Cost Of Services Amortization
CostOfServicesAmortization
556000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3436000
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18000
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
195000
CY2012 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2012 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
2900
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
319000
CY2012 us-gaap Depreciation
Depreciation
188000
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
325600
CY2012 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
896000
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7080000
CY2012 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
CY2012 onvo Net Proceeds From Issuance Of Private Placement
NetProceedsFromIssuanceOfPrivatePlacement
11593066
CY2012 onvo Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
13532487 shares
CY2012 onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
24714000
CY2012 onvo Gross Proceeds From Issuance Of Private Placement
GrossProceedsFromIssuanceOfPrivatePlacement
13722600
CY2012 onvo Accrued Interest On Convertible Notes
AccruedInterestOnConvertibleNotes
25000
CY2012 onvo Convertible Notes Principal Amount
ConvertibleNotesPrincipalAmount
1500000
CY2012 onvo Adjustments To Additional Paid In Capital Loss On Inducement To Exercise Warrants
AdjustmentsToAdditionalPaidInCapitalLossOnInducementToExerciseWarrants
1904000
CY2012 onvo Adjustments To Additional Paid In Capital Warrant Liability From Exercises Of Warrants
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityFromExercisesOfWarrants
23321000
CY2012 onvo Closings Of Subscription Under Private Placement
ClosingsOfSubscriptionUnderPrivatePlacement
3 Private_placement
CY2012 onvo Costs Associated With Merger
CostsAssociatedWithMerger
13723000
CY2012 onvo Deduction In Warrant Liability
DeductionInWarrantLiability
23321000
CY2012 onvo Derivative Liabilities Exceeded Proceeds Amount
DerivativeLiabilitiesExceededProceedsAmount
19019400
CY2012 onvo Duration After Which Warrants Are Exercisable
DurationAfterWhichWarrantsAreExercisable
P5Y
CY2012 onvo Expense Allowance Paid To Placement Agent
ExpenseAllowancePaidToPlacementAgent
411678
CY2012 onvo Fair Value Of Warrant Liabilities In Excess Of Proceeds Received
FairValueOfWarrantLiabilitiesInExcessOfProceedsReceived
19019000
CY2012 onvo Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
162000
CY2012 onvo Interest Accrued On Convertible Notes Payable
InterestAccruedOnConvertibleNotesPayable
12000
CY2012 onvo Issuance Of Common Stock Through Conversion Of Notes Payable And Accrued Interest In Connection With Merger
IssuanceOfCommonStockThroughConversionOfNotesPayableAndAccruedInterestInConnectionWithMerger
1526000
CY2012 onvo Issuance Of Common Stock Through Private Placements In Connection With Merger
IssuanceOfCommonStockThroughPrivatePlacementsInConnectionWithMerger
13723000
CY2012 onvo Issuance Of Common Stock To Note Holders Shares
IssuanceOfCommonStockToNoteHoldersShares
1525387 shares
CY2012 onvo Issued Warrants To Purchase Share Of Common Stock For Consulting Services Shares
IssuedWarrantsToPurchaseShareOfCommonStockForConsultingServicesShares
650000 shares
CY2012 onvo Loss On Inducement To Exercise
LossOnInducementToExercise
1904000
CY2012 onvo Penalty Period
PenaltyPeriod
P30D
CY2012 onvo Private Placement Securities Price Per Unit
PrivatePlacementSecuritiesPricePerUnit
1.00
CY2012 onvo Purchased Equipment Through Capital Lease
PurchasedEquipmentThroughCapitalLease
34000
CY2012 onvo Registration Rights Agreement Filing Deadline
RegistrationRightsAgreementFilingDeadline
P90D
CY2012 onvo Registration Rights Agreement Penalty Percentage On Failure To Meet Effectiveness Deadline
RegistrationRightsAgreementPenaltyPercentageOnFailureToMeetEffectivenessDeadline
0.005 pure
CY2012 onvo Repayment Of Convertible Notes And Interest Payable
RepaymentOfConvertibleNotesAndInterestPayable
110000
CY2012 onvo Revenue From Collaborations
RevenueFromCollaborations
1035000
CY2012 onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
13423622 shares
CY2012 onvo Stockholders Equity During Period Value Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodValueIssuanceOfCommonStockFromWarrantExercises
10991000
CY2012 onvo Transferred Amount Of Inventory To Fixed Assets
TransferredAmountOfInventoryToFixedAssets
391000
CY2012 onvo Warrant Or Right Expense Or Revenue Recognized
WarrantOrRightExpenseOrRevenueRecognized
556000
CY2012 onvo Warrants Issued To Placement Agent For Purchase Of Common Stock
WarrantsIssuedToPlacementAgentForPurchaseOfCommonStock
6099195 shares
CY2012 onvo Increase Decrease In Cash Deposits Released From Restriction
IncreaseDecreaseInCashDepositsReleasedFromRestriction
-88000
CY2012 onvo Issued Warrants To Purchase Shares Of Common Stock Or Consulting Services
IssuedWarrantsToPurchaseSharesOfCommonStockOrConsultingServices
890000
CY2012 onvo Number Of Offerings Under Private Placement Reverse Merger
NumberOfOfferingsUnderPrivatePlacementReverseMerger
3 Private_placement
CY2012 onvo Number Of Agreement With Consultants For Services
NumberOfAgreementWithConsultantsForServices
4 Agreement
CY2012 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
13010237 shares
CY2012 onvo Number Of Warrants In Each Unit
NumberOfWarrantsInEachUnit
1 shares
CY2012 onvo Number Of Common Stock Shares For Each Unit
NumberOfCommonStockSharesForEachUnit
1 shares
CY2012 onvo Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Forfeited Cancelled Surrendered In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedCancelledSurrenderedInPeriod
95842 shares
CY2013Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2016-08-01
CY2013Q4 onvo Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
38800
CY2013Q4 onvo Additional Office Space
AdditionalOfficeSpace
14500 sqft
CY2013Q4 onvo Operating Leases Monthly Rent Expense
OperatingLeasesMonthlyRentExpense
38934
CY2013Q4 onvo Office Space Area Under Lease Agreement
OfficeSpaceAreaUnderLeaseAgreement
30807 sqft
CY2012Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
21247987 shares
CY2011Q4 onvo Duration After Which Warrants Are Exercisable
DurationAfterWhichWarrantsAreExercisable
P5Y
CY2011Q4 onvo Warrants To Purchase Share Of Common Stock
WarrantsToPurchaseShareOfCommonStock
1500000 shares
CY2011Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
740000
CY2011Q3 onvo Conversion Price As Percentage Of Fair Market Value
ConversionPriceAsPercentageOfFairMarketValue
0.75 pure
CY2014Q1 us-gaap Interest Expense
InterestExpense
13000
CY2014Q1 onvo Amortization Of Debt Discount Premium Recorded Till Date
AmortizationOfDebtDiscountPremiumRecordedTillDate
1500000
CY2014Q1 onvo Federal Research Tax Credit Carry Forwards Expiration Year Start
FederalResearchTaxCreditCarryForwardsExpirationYearStart
2028
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
55000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0119 pure
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9683 pure
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y26D
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61750157 shares
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.93
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2755000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.04
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
927981 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2013Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8900000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
221302 shares
CY2013Q1 us-gaap Revenues
Revenues
215000
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
61000
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
4000
CY2013Q1 us-gaap Profit Loss
ProfitLoss
-16120000
CY2013Q1 us-gaap Revenue From Grants
RevenueFromGrants
117000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4025000
CY2013Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
19000
CY2013Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
CY2013Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
117000
CY2013Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
2000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12095000
CY2013Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
848000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
137000
CY2013Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
12034000
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3722000
CY2013Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
62000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
848000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
811000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-156000
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-201000
CY2013Q1 us-gaap Interest Expense
InterestExpense
65000
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
216000
CY2013Q1 us-gaap Cost Of Services Amortization
CostOfServicesAmortization
261000
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1448000
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
80000
CY2013Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2013Q1 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
1700
CY2013Q1 us-gaap Depreciation
Depreciation
78000
CY2013Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
105500
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2792000
CY2013Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
CY2013Q1 onvo Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
7090556 shares
CY2013Q1 onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
3724000
CY2013Q1 onvo Adjustments To Additional Paid In Capital Expense On Modification Of Warrant
AdjustmentsToAdditionalPaidInCapitalExpenseOnModificationOfWarrant
65000
CY2013Q1 onvo Adjustments To Additional Paid In Capital Warrant Liability From Exercises Of Warrants
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityFromExercisesOfWarrants
23869000
CY2013Q1 onvo Adjustments To Additional Paid In Capital Warrant Liability Reclassified To Equity
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityReclassifiedToEquity
1886000
CY2013Q1 onvo Cashless Exercise For Issuance Of Common Stock
CashlessExerciseForIssuanceOfCommonStock
58220 shares
CY2013Q1 onvo Deduction In Warrant Liability
DeductionInWarrantLiability
23869000
CY2013Q1 onvo Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-61000
CY2013Q1 onvo Payment For Expense On Warrant Modification
PaymentForExpenseOnWarrantModification
65000
CY2013Q1 onvo Revenue From Collaborations
RevenueFromCollaborations
98000
CY2013Q1 onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
6131198 shares
CY2013Q1 onvo Stockholders Equity During Period Value Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodValueIssuanceOfCommonStockFromWarrantExercises
3724000
CY2013Q1 onvo Transferred Amount Of Inventory To Fixed Assets
TransferredAmountOfInventoryToFixedAssets
272000
CY2013Q1 onvo Warrant Or Right Expense Or Revenue Recognized
WarrantOrRightExpenseOrRevenueRecognized
261000
CY2013Q1 onvo Warrant Reclassified Equity Instruments
WarrantReclassifiedEquityInstruments
1886000
CY2013Q1 onvo Warrants Cashless Exercise Number
WarrantsCashlessExerciseNumber
100000 shares
CY2013Q1 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
6990556 shares
CY2013Q1 onvo Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Forfeited Cancelled Surrendered In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedCancelledSurrenderedInPeriod
10000 shares
CY2012Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31591663 shares
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3556000
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.17
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25800000 shares
CY2012Q1 us-gaap Revenues
Revenues
120000
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
65000
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
CY2012Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
CY2012Q1 us-gaap Profit Loss
ProfitLoss
-37081000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1329000
CY2012Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
CY2012Q1 us-gaap Interest Paid
InterestPaid
10000
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-35752000
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
45000
CY2012Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000
CY2012Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
13506000
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
13613000
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
116000
CY2012Q1 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
2130000
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4000
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10013000
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-44000
CY2012Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-37000
CY2012Q1 us-gaap Interest Expense
InterestExpense
1088000
CY2012Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-217000
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
547000
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17000
CY2012Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2012Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
319000
CY2012Q1 us-gaap Depreciation
Depreciation
15000
CY2012Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
60200
CY2012Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
896000
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
902000
CY2012Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
CY2012Q1 onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
13723000
CY2012Q1 onvo Fair Value Of Warrant Liabilities In Excess Of Proceeds Received
FairValueOfWarrantLiabilitiesInExcessOfProceedsReceived
19019000
CY2012Q1 onvo Interest Accrued On Convertible Notes Payable
InterestAccruedOnConvertibleNotesPayable
12000
CY2012Q1 onvo Repayment Of Convertible Notes And Interest Payable
RepaymentOfConvertibleNotesAndInterestPayable
110000
CY2012Q1 onvo Revenue From Collaborations
RevenueFromCollaborations
120000
CY2012Q1 onvo Increase Decrease In Cash Deposits Released From Restriction
IncreaseDecreaseInCashDepositsReleasedFromRestriction
-38000

Files In Submission

Name View Source Status
0001193125-14-232145-index-headers.html Edgar Link pending
0001193125-14-232145-index.html Edgar Link pending
0001193125-14-232145.txt Edgar Link pending
0001193125-14-232145-xbrl.zip Edgar Link pending
d690346d10k.htm Edgar Link pending
d690346dex231.htm Edgar Link pending
d690346dex311.htm Edgar Link pending
d690346dex312.htm Edgar Link pending
d690346dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g690346g36n62.jpg Edgar Link pending
onvo-20140331.xml Edgar Link completed
onvo-20140331.xsd Edgar Link pending
onvo-20140331_cal.xml Edgar Link unprocessable
onvo-20140331_def.xml Edgar Link unprocessable
onvo-20140331_lab.xml Edgar Link unprocessable
onvo-20140331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending